Okay, let's tackle this question about sphingomyelinase deficiency. The question is asking which disease is associated with a deficiency in this enzyme. The correct answer is Niemann-Pick disease.

First, I need to recall the core concept here. Sphingomyelinase is an enzyme that breaks down sphingomyelin, a component of cell membranes. When there's a deficiency, sphingomyelin can't be metabolized properly, leading to its accumulation in cells. This is a lysosomal storage disorder, right?

So, Niemann-Pick disease is a group of inherited metabolic disorders. The main types are A, B, and C. Type A and B are due to a deficiency in acid sphingomyelinase, which leads to the accumulation of sphingomyelin in the spleen, liver, lungs, and brain. Type C is different because it's caused by mutations in the NPC1 or NPC2 genes, which affect cholesterol transport rather than sphingomyelinase activity. So Type C isn't related to sphingomyelinase deficiency.

Now, looking at the other options. If the options included Gaucher's disease, that's due to glucocerebrosidase deficiency. Tay-Sachs is from hexosaminidase A deficiency. Krabbe disease is from galactocerebrosidase deficiency. Fabry disease is from alpha-galactosidase A. Each of these is a different lysosomal storage disorder with their own enzyme deficiencies.

The clinical pearl here is to remember that Niemann-Pick (types A and B) specifically involves sphingomyelinase deficiency, while type C is a separate entity. Also, the cherry-red spot in the retina is a classic sign of Niemann-Pick type A. So students should note the difference between the types and their associated enzyme deficiencies.

**Core Concept**
Sphingomyelinase deficiency leads to the accumulation of sphingomyelin in lysosomes, causing Niemann-Pick disease (types A and B). This is a **lysosomal storage disorder** characterized by **neurological degeneration, hepatosplenomegaly, and systemic lipid accumulation**.

**Why the Correct Answer is Right**
Niemann-Pick disease results from mutations in the **SMPD1 gene**, encoding **acid sphingomyelinase**. Deficiency of this enzyme prevents the hydrolysis of sphingomyelin to ceramide and phosphorylcholine, causing **lysosomal accumulation of sphingomyelin** in macrophages, neurons, and other cells. Types A and B are autosomal recessive, with type A being more severe and presenting in infancy with neurodegeneration and cherry-red macula.

**Why Each Wrong Option is Incorrect**
**Option A:** Gaucher disease is caused by **glucocerebrosidase deficiency**, leading to glucocerebroside accumulation.
**Option B:** Tay-Sachs disease is due to **hexosaminidase A deficiency**, resulting in GM2 ganglioside storage.
**Option C:** Fabry disease involves **alpha-galactosidase A deficiency**, causing globotriaosylceramide accumulation.
**Option D:** Krabbe disease stems from **galactocerebrosidase deficiency**, leading to galactocerebroside buildup.

**Clinical Pearl /

✓ Correct Answer: A. Niemann - Pick disease